Key Benefits and Clinical Applications of DXT

• Clinically proven output:
  ‍DXT measures diaphragm excursion (DE) and respiratory rate (RR) in real-time including trends. DXT has a well-established cut-off value to detect patients at increased risk of reintubation during the weaning process from MV.
• Medical Need:
  ‍By identifying patients at increased risk of extubation failure during the weaning process from mechanical ventilation, RESPINOR DXT has the potential to improve decision making and reduce the number of emergency re-intubations, and potential morbidity associated with mechanical ventilation, as well as ICU and hospital length of stay.
• Purpose:
  ‍DXT aims to optimize extubation timing, reduce re-intubation rates, improve patient outcomes, and thereby lower healthcare costs.
• Technology:
  DXT uses sensors with optimized design for patient comfort, continuous monitoring, and computer-aided sensor placement.
• Non-Invasive:
  DXT offers a non-invasive solution for monitoring diaphragm function.
• Good safety profile:
  A total of 389 patients been monitored with DXT through the clinical development, and no serious adverse device effects have been reported
• Product:
  ‍RESPINOR DXT is a medical technology designed to provide an objective measure of diaphragm function.